Tokyo Tape
Sign in
← Ubicom Holdings

Half-year report · Q2

3937.TEDINET S100UMD4
Period2024-04-01 → 2024-09-30
Filed2024-11-07
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥3.1bn2024-04-01 → 2024-09-30Cons.Net sales
Revenue¥5.9bn2023-04-01 → 2024-03-31Cons.Net sales (5-year summary)
Revenue¥2.9bn2023-04-01 → 2023-09-30Cons.Net sales
Operating income¥591m2024-04-01 → 2024-09-30Cons.Operating income
Operating income¥541m2023-04-01 → 2023-09-30Cons.Operating income
Ordinary income¥629m2024-04-01 → 2024-09-30Cons.Ordinary income
Ordinary income¥936m2023-04-01 → 2024-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥467m2023-04-01 → 2023-09-30Cons.Ordinary income
Profit before tax¥629m2024-04-01 → 2024-09-30Cons.Income before income taxes
Profit before tax¥467m2023-04-01 → 2023-09-30Cons.Income before income taxes
Net income (owners)¥443m2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥526m2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥301m2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income¥443m2024-04-01 → 2024-09-30Cons.Profit loss
Net income¥301m2023-04-01 → 2023-09-30Cons.Profit loss
Total assets¥7.2bnat 2024-09-30Cons.Assets
Total assets¥6.9bnat 2024-03-31Cons.Assets
Total assets¥6.4bnat 2023-09-30Cons.Total assets (5-year summary)
Total liabilities¥2.1bnat 2024-09-30Cons.Liabilities
Total liabilities¥2.2bnat 2024-03-31Cons.Liabilities
Net assets / equity¥5.1bnat 2024-09-30Cons.Net assets
Net assets / equity¥4.7bnat 2024-03-31Cons.Net assets
Net assets / equity¥4.4bnat 2023-09-30Cons.Net assets (5-year summary)
Cash and deposits¥4.6bnat 2024-09-30Cons.Cash and deposits
Cash and deposits¥4.0bnat 2024-03-31Cons.Cash and deposits
Cash & equivalents¥4.6bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥4.0bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥3.8bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥3.6bnat 2023-03-31dCons.Cash and cash equivalents
Operating cash flow¥651m2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥727m2023-04-01 → 2024-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥504m2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥39m2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥273m2023-04-01 → 2024-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥221m2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥57m2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥155m2023-04-01 → 2024-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥169m2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥36.872024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥44.732023-04-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥25.572023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥36.812024-04-01 → 2024-09-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥44.152023-04-01 → 2024-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥25.12023-04-01 → 2023-09-30Cons.Diluted earnings per share (5-year summary)
Equity ratio70.5%at 2024-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio68.2%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio67.8%at 2023-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 40
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2024-04-01 → 2024-09-30−¥22m
Reconciling Itemsreconcilingrevenue intersegment2024-04-01 → 2024-09-30−¥22m
Reconciling Itemsreconcilingsegment profit2024-04-01 → 2024-09-30−¥190m
jpcrp040300-q2r_E32408-000Globalreportable segmentrevenue2024-04-01 → 2024-09-30¥2.3bn
jpcrp040300-q2r_E32408-000Globalreportable segmentrevenue external2024-04-01 → 2024-09-30¥2.3bn
jpcrp040300-q2r_E32408-000Globalreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥15m
jpcrp040300-q2r_E32408-000Globalreportable segmentsegment profit2024-04-01 → 2024-09-30¥240m
jpcrp040300-q2r_E32408-000Medicalreportable segmentrevenue2024-04-01 → 2024-09-30¥847m
jpcrp040300-q2r_E32408-000Medicalreportable segmentrevenue external2024-04-01 → 2024-09-30¥841m
jpcrp040300-q2r_E32408-000Medicalreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥6m
jpcrp040300-q2r_E32408-000Medicalreportable segmentsegment profit2024-04-01 → 2024-09-30¥542m
—segment totalrevenue2024-04-01 → 2024-09-30¥3.2bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥3.1bn
—segment totalrevenue intersegment2024-04-01 → 2024-09-30¥22m
—segment totalsegment profit2024-04-01 → 2024-09-30¥781m
Total Of Reportable Segments And Otherssegment totalrevenue2024-04-01 → 2024-09-30¥3.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-04-01 → 2024-09-30¥3.1bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2024-04-01 → 2024-09-30¥22m
Total Of Reportable Segments And Otherssegment totalsegment profit2024-04-01 → 2024-09-30¥781m
Otherother segmentsrevenue2023-04-01 → 2023-09-30¥600,000
Otherother segmentsrevenue external2023-04-01 → 2023-09-30¥600,000
Otherother segmentssegment profit2023-04-01 → 2023-09-30¥300,000
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-09-30−¥17m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-09-30−¥17m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥170m
jpcrp040300-q2r_E32408-000Globalreportable segmentrevenue2023-04-01 → 2023-09-30¥2.1bn
jpcrp040300-q2r_E32408-000Globalreportable segmentrevenue external2023-04-01 → 2023-09-30¥2.1bn
jpcrp040300-q2r_E32408-000Globalreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥17m
jpcrp040300-q2r_E32408-000Globalreportable segmentsegment profit2023-04-01 → 2023-09-30¥233m
jpcrp040300-q2r_E32408-000Medicalreportable segmentrevenue2023-04-01 → 2023-09-30¥798m
jpcrp040300-q2r_E32408-000Medicalreportable segmentrevenue external2023-04-01 → 2023-09-30¥798m
jpcrp040300-q2r_E32408-000Medicalreportable segmentsegment profit2023-04-01 → 2023-09-30¥477m
—segment totalrevenue2023-04-01 → 2023-09-30¥2.9bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥2.9bn
—segment totalrevenue intersegment2023-04-01 → 2023-09-30¥17m
—segment totalsegment profit2023-04-01 → 2023-09-30¥711m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥2.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥2.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-09-30¥17m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥711m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 495
ItemContextValueUnit
Net salesPrior1YTDDuration2929925000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E32408-000GlobalReportableSegmentMember233279000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E32408-000MedicalReportableSegmentMember477447000JPY
Operating incomePrior1YTDDuration_ReportableSegmentsMember710726000JPY
Operating incomePrior1YTDDuration_OtherReportableSegmentsMember300000JPY
Operating incomePrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember711026000JPY
Operating incomePrior1YTDDuration_ReconcilingItemsMember-169863000JPY
Operating incomePrior1YTDDuration541162000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E32408-000GlobalReportableSegmentMember2297621000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E32408-000MedicalReportableSegmentMember840880000JPY
Revenues from external customersCurrentYTDDuration_ReportableSegmentsMember3138502000JPY
Revenues from external customersCurrentYTDDuration_OtherReportableSegmentsMember－JPY
Revenues from external customersCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember3138502000JPY
Revenues from external customersCurrentYTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersCurrentYTDDuration3138502000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E32408-000GlobalReportableSegmentMember15194000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E32408-000MedicalReportableSegmentMember6462000JPY
Transactions with other segmentsCurrentYTDDuration_ReportableSegmentsMember21657000JPY
Transactions with other segmentsCurrentYTDDuration_OtherReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember21657000JPY
Transactions with other segmentsCurrentYTDDuration_ReconcilingItemsMember-21657000JPY
Transactions with other segmentsCurrentYTDDuration－JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E32408-000GlobalReportableSegmentMember2312815000JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E32408-000MedicalReportableSegmentMember847343000JPY
Net salesCurrentYTDDuration_ReportableSegmentsMember3160159000JPY
Net salesCurrentYTDDuration_OtherReportableSegmentsMember－JPY
Net salesCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember3160159000JPY
Net salesCurrentYTDDuration_ReconcilingItemsMember-21657000JPY
Net salesCurrentYTDDuration3138502000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q2r_E32408-000GlobalReportableSegmentMember239544000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q2r_E32408-000MedicalReportableSegmentMember541784000JPY
Operating incomeCurrentYTDDuration_ReportableSegmentsMember781329000JPY
Operating incomeCurrentYTDDuration_OtherReportableSegmentsMember－JPY
Operating incomeCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember781329000JPY
Operating incomeCurrentYTDDuration_ReconcilingItemsMember-189971000JPY
Operating incomeCurrentYTDDuration591357000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の５第１項の表の第１号
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2024-11-07
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第20期中(自　2024年４月１日　至　2024年９月30日)
Company name cover pageFilingDateInstant
Original text (Japanese)株式会社Ubicomホールディングス
Company name in english cover pageFilingDateInstantUbicom Holdings, Inc.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　青木　正之
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都千代田区一番町21
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)03-5803-7339（代表）
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)取締役コーポレート本部長　北岡　明哲
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都千代田区一番町21
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)03-5803-7339（代表）
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)取締役コーポレート本部長　北岡　明哲

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-03-31pass rounding
balance sheet identityconsolidated 2024-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net assetsconsolidated 2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass